This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

New First Trust ETF Combines Two Successful Methodologies

NEW YORK (TheStreet) -- Earlier this week First Trust launched the First Trust Dorsey Wright Focus 5 ETF (FV) which is a fund of funds that combines First Trust's suite of industry and AlphaDEX sector funds with a momentum strategy overlay built on relative strength managed by Dorsey Wright & Associates.

The term AlphaDEX in the name of the sector funds refers to the quantitative screening process that considers fundamentals such as book value, cash flow and price to sales. All nine AlphaDEX sector funds have outperformed their corresponding Select Sector SPDR ETFs for one and five year periods.

First Trust also offers a wide range of narrow industry and niche funds from all of the broad sectors.

Dorsey Wright manages several funds for PowerShares that apply the DWA relative strength model to individual stocks. Three of the longer tenured PowerShares funds include the PowerShares DWA Developed Markets Momentum Portfolio (PIZ), PowerShares DWA Emerging Markets Momentum Portfolio (PIE) and PowerShares DWA Momentum Portfolio (PDP) and all three have outperformed their corresponding market cap weighted benchmark fund for five years and two of the three have outperformed for one year.

The process for FV is very straightforward. DWA will screen First Trust's universe of sector and industry funds and rank them for relative strength and the top five will populate the fund. The screening will occur weekly and the fund will be reconstituted as required based on and changes in the rankings.

The current makeup of the fund allocates 22% to First Trust NYSE Arca Biotechnology Index Fund (FBT), 21% to First Trust Dow Jones Internet Index Fund (FDN), 20% in First Trust Health Care AlphaDEX Fund (FXH) and 18% each in First Trust Consumer Discretionary AlphaDEX Fund (FXD) and First Trust Consumer Staples AlphaDEX Fund (FXG).

The respective performances of the AlphaDEX funds and Dorsey Wright & Associates PowerShares funds makes the combination of the two under the hood of FV an interesting idea but the potential drawbacks need to be understood.

The fund is not well diversified in terms of sector and industry allocation. The current mix has 40% in health care, 40% in consumer and 20% in what is arguably the consumer part of technology. Even if the five holdings came from five different sectors it would still not capture the broad market. Obviously the argument behind the fund is that investors should not own sectors with poor relative strength.

Another potential risk is relatively large exposure to an individual stock. Google (GOOG) has an almost 10% weighting in FDN which means Google has about a 2% weighting in FVA's current allocation. The answer to how much it too much is up to the individual but should be monitored for anyone who believes 2 to 3% in one stock is a lot.

FVA's expense ratio is 0.95% which accounts for a 0.30% management fee along with a 0.65% acquired fund fees which is the expense ratio of the ETFs that FV will use.

For as well as the AlphaDEX funds have done over what is a reasonably long period of time do investors need to pay the extra 30 basis points for the best of the best?

There can be no assurances that combining two market beating track records will result in even greater outperformance but the new fund makes a good first impression.

At the time of publication the author held no positions in any of the stocks mentioned.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
FV $23.70 -0.04%
PIZ $25.16 0.04%
AAPL $124.24 0.00%
FB $83.01 0.00%
GOOG $555.17 0.00%

Markets

DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs